Kinetics of strain-dependent differential gene expression in oxygen-induced retinopathy in the rat

Experimental Eye Research

Volumn 85, Issue 4, 2007, Pages 508-517

  van Wijngaarden, Peter ^a   Brereton, Helen M ^a   Gibbins, Ian L ^a   Coster, Douglas J ^a   Williams, Keryn A ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

angiogenesis; gene expression; hyperoxia; oxygen induced retinopathy; retina; retinopathy of prematurity; reverse transcriptase polymerase chain reaction

Indexed keywords

ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; CYCLOOXYGENASE 2; ERYTHROPOIETIN; MESSENGER RNA; OXYGEN; PIGMENT EPITHELIUM DERIVED FACTOR; SOMATOMEDIN C; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DARK AGOUTI RAT; DISEASE MODEL; FEMALE; FISCHER 344 RAT; GENE EXPRESSION; GENETICS; HYPEROXIA; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RETINA; RETINOPATHY; SPRAGUE DAWLEY RAT; STATISTICAL SIGNIFICANCE; STRAIN DIFFERENCE;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; DISEASE MODELS, ANIMAL; EYE PROTEINS; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT, NEWBORN; NEOVASCULARIZATION, PATHOLOGIC; NERVE GROWTH FACTORS; OXYGEN; RATS; RATS, INBRED STRAINS; RETINA; RETINOPATHY OF PREMATURITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERPINS; SPECIES SPECIFICITY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34948839484     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2007.07.001     Document Type: Article

References (41)

1. Abdulmalek K., Ashur F., Ezer N., Ye F., Magder S., and Hussain S.N. Differential expression of Tie-2 receptors and angiopoietins in response to in vivo hypoxia in rats. Am. J. Physiol. Lung Cell Mol. Physiol. 281 (2001) L582-L590
2. Aiello L.P. Vascular endothelial growth factor. 20th-century mechanisms, 21st-century therapies. Invest. Ophthalmol. Vis. Sci. 38 (1997) 1647-1652
3. Alon T., Hemo I., Itin A., Pe'er J., Stone J., and Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med. 1 (1995) 1024-1028
4. Chan C.K., Pham L.N., Zhou J., Spee C., Ryan S.J., and Hinton D.R. Differential expression of pro- and antiangiogenic factors in mouse strain-dependent hypoxia-induced retinal neovascularization. Lab. Invest. 85 (2005) 721-733
5. Chan-Ling T., and Stone J. Retinopathy of prematurity: its origins in the architecture of the retina. Prog. Ret. Res. 12 (1993) 155-178
6. Cooke R.W.I., Drury J.A., Mountford R., and Clark D. Genetic polymorphisms and retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 45 (2004) 1712-1715
7. Cunningham S., McColm J.R., Wade J., Sedowofia K., McIntosh N., and Fleck B. A novel model of retinopathy of prematurity simulating preterm oxygen variability in the rat. Invest. Ophthalmol. Vis. Sci. 41 (2000) 4275-4280
8. Dawson D.W., Volpert O.V., Gillis P., et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 285 (1999) 245-248
9. Floyd B.N., Leske D.A., Wren S.M., Mookadam M., Fautsch M.P., and Holmes J.M. Differences between rat strains in models of retinopathy of prematurity. Mol. Vis. 11 (2005) 524-530
10. Gao G., Li Y., Zhang D., Gee S., Crosson C., and Ma J. Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization. FEBS Lett. 489 (2001) 270-276
11. Gao G., Li Y., Fant J., Crosson C.E., Becerra S.P., and Ma J.X. Difference in ischemic regulation of vascular endothelial growth factor and pigment epithelium-derived factor in Brown Norway and Sprague Dawley rats contributing to different susceptibilities to retinal neovascularization. Diabetes 51 (2002) 1218-1225
12. Gupta A.R., Dejneka N.S., D'Amato R.J., et al. Strain-dependent anterior segment neovascularization following intravitreal gene transfer of basic fibroblast growth factor (bFGF). J. Gene Med. 3 (2001) 252-259
13. Hellstrom A., Perruzzi C., Ju M., et al. Low IGF-1 suppresses VEGF-survival signalling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 5804-5808
14. Kim S.Y., Mocanu C., Mcleod D.S., et al. Expression of pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in sickle cell retina and choroid. Exp. Eye Res. 77 (2003) 433-445
15. Kinsey V.E., Jacobus J.T., and Hemphill F.M. Cooperative study of retrolental fibroplasia and the use of oxygen. Arch. Ophthalmol. 56 (1956) 481-529
16. Lukiw W.J., Ottlecz A., Lambrou G., et al. Coordinate activation of HIF-1 and NF-kappaB DNA binding and COX-2 and VEGF expression in retinal cells by hypoxia. Invest. Ophthalmol. Vis. Sci. 44 (2003) 4163-4170
17. Morita M., Ohneda O., Yamashita T., et al. HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin. EMBO J. 22 (2003) 1134-1146
18. Notari L., Miller A., Martinez A., et al. Pigment epithelium-derived factor is a substrate for matrix metalloproteinase type 2 and type 9: implications for downregulation in hypoxia. Invest. Ophthalmol. Vis. Sci. 46 (2005) 2736-2747
19. Ohno-Matsui K., Morita I., Tombran-Tink J., et al. Novel mechanism for age-related macular degeneration: an equilibrium shift between the angiogenesis factors VEGF and PEDF. J. Cell Physiol. 189 (2001) 323-333
20. Penn J.S., Tolman B.L., and Lowery L.A. Variable oxygen exposure causes preretinal neovascularization in the newborn rat. Invest. Ophthalmol. Vis. Sci. 34 (1993) 576-585
21. Petrova T.V., Makinen T., and Alitalo K. Signaling via vascular endothelial growth factor receptors. Exper. Cell Res. 253 (1999) 117-130
22. Pierce E.A., Foley E.D., and Smith L.E. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. Arch. Ophthalmol. 114 (1996) 1219-1228
23. Quinn G.E., Dobson V., Barr C.C., et al. Visual acuity in infants after vitrectomy for severe retinopathy of prematurity. Ophthalmology 98 (1991) 5-13
24. Ririe K.M., Rasmussen R.P., and Wittwer C.T. Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Anal. Biochem. 45 (1997) 154-160
25. Robbins S.G., Rajaratnam V.S., and Penn J.S. Evidence for upregulation and redistribution of vascular endothelial growth factor (VEGF) receptors flt-1 and flk-1 in the oxygen-injured rat retina. Growth Factors 16 (1998) 1-9
26. Rogers M.S., Rohan R.M., Birsner A.E., and D'Amato R.J. Genetic loci that control vascular endothelial growth factor-induced angiogenesis. FASEB J. 17 (2003) 2112-2114
27. Rogers M.S., Rohan R.M., Birsner A.E., and D'Amato R.J. Genetic loci that control the angiogenic response to basic fibroblast growth factor. FASEB J. 18 (2004) 1050-1059
28. Rohan R.M., Fernandez A., Udagawa T., Yuan J., and D'Amato R.J. Genetic heterogeneity of angiogenesis in mice. FASEB J. 14 (2000) 871-876
29. Roze S., and Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S., and Misener S. (Eds). Bioinformatics Methods and Protocols in the Series Methods in Molecular Biology (2000), Humana Press, Totowa, NJ 365-386
30. Saunders R.A., Donahue M.L., Christmann L.M., et al. Racial variation in retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch. Ophthalmol. 115 (1997) 604-608
31. Smith L.E.H., Shen W., Perruzzi C., et al. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat. Med. 12 (1999) 1390-1395
32. Stone J., Chan-Ling T., Pe'er J., Itin A., Gnessin H., and Keshet E. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Invest. Ophthalmol. Vis Sci. 37 (1996) 290-299
33. Suzuma K., Takagi H., Otani A., Suzuma I., and Honda Y. Increased expression of KDR/Flk-1 (VEGFR-2) in murine model of ischemia-induced retinal neovascularization. Microvasc. Res. 56 (1998) 183-191
34. van Wijngaarden P., Coster D.J., Brereton H.M., Gibbins I.L., and Williams K.A. Strain-dependent differences in oxygen-induced retinopathy in the inbred rat. Invest. Ophthalmol. Vis. Sci. 46 (2005) 1445-1452
35. van Wijngaarden P., Brereton H.M., Coster D.J., and Williams K.A. Genetic influences on susceptibility to oxygen-induced retinopathy. Invest. Ophthalmol. Vis. Sci. 48 (2007) 1761-1766
36. van Wijngaarden, P., Brereton, H.M., Coster, D.J., Williams, K.A. Stability of housekeeping gene expression in the rat retina during exposure to cyclic hyperoxia. Mol. Vis., in press.
37. Vandesompele J., De Preter K., Pattyn F., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3 7 (2002) research0034.1-0034.11
38. Vinores S.A., Xiao W.H., Aslam S., et al. Implication of the hypoxia response element of the Vegf promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development. J. Cell Physiol. 206 (2006) 749-758
39. Wilkinson-Berka J.L., Alousis N.S., Kelly D.J., and Gilbert R.E. COX-2 inhibition and retinal angiogenesis in a mouse model of retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 44 (2003) 974-979
40. Zhang S.X., Ma J.X., Sima J., Chen Y., Hu M.S., Ottlecz A., and Lambrou G.N. Genetic difference in susceptibility to the blood-retina barrier breakdown in diabetes and oxygen-induced retinopathy. Am. J. Pathol. 166 (2005) 313-321
41. Zhang Y., and Stone J. Role of astrocytes in the control of developing retinal vessels. Invest. Ophthalmol. Vis. Sci. 38 (1997) 1653-1666